WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012103314) METHODS OF TREATING TACHYCARDIA AND/OR CONTROLLING HEART RATE WHILE MINIMIZING AND/OR CONTROLLING HYPOTENSION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/103314    International Application No.:    PCT/US2012/022696
Publication Date: 02.08.2012 International Filing Date: 26.01.2012
Chapter 2 Demand Filed:    27.11.2012    
IPC:
A61K 31/24 (2006.01), A61P 9/06 (2006.01)
Applicants: BAXTER INTERNATIONAL INC. [US/US]; One Baxter Parkway Deerfield, IL 60015 (US) (For All Designated States Except US).
BAXTER HEALTHCARE S.A. [CH/CH]; Thurgauerstrasse 130 CH-8152 Glattpark (Opfikon) (CH) (For All Designated States Except US).
RABINOW, Barrett [US/US]; (US) (For US Only).
MCKEE, Jeff [US/US]; (US) (For US Only)
Inventors: RABINOW, Barrett; (US).
MCKEE, Jeff; (US)
Agent: LAWRENCE, Andrew, M.; Marshall, Gerstein & Borun LLP 233 S. Wacker Drive 6300 Willis Tower Chicago, IL 60606-6357 (US)
Priority Data:
61/436,992 27.01.2011 US
Title (EN) METHODS OF TREATING TACHYCARDIA AND/OR CONTROLLING HEART RATE WHILE MINIMIZING AND/OR CONTROLLING HYPOTENSION
(FR) MÉTHODES PERMETTANT DE TRAITER LA TACHYCARDIE ET/OU DE RÉGULER LA FRÉQUENCE CARDIAQUE TOUT EN MINIMISANT ET/OU RÉGULANT L'HYPOTENSION
Abstract: front page image
(EN)A method of treating tachycardia while minimizing and/or controlling hypotension associated with such treatment includes administering a therapeutically effective amount of a pharmaceutical composition comprising the S-isomer of esmolol to a subject in need thereof.
(FR)La présente invention concerne une méthode permettant de traiter la tachycardie tout en minimisant et/ou régulant l'hypotension associée à un tel traitement. Ladite méthode comprend l'administration d'une quantité thérapeutiquement efficace d'une composition pharmaceutique comportant le S-isomère d'esmolol à un sujet en ayant besoin.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)